Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Insight Molecular Diagnostics Inc. shareholders approved To elect five (5) directors to hold office until the next annual meeting of shareholders and until their respective successors are duly elected and qualified. at the 2023-06-23 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-23
Exact text from the filing
1. Election of Directors Shares Voted Director Nominee For Withheld Broker Non-Votes Joshua Riggs 83,530,246 867,017 43,376,020 Andrew Arno 83,418,588 978,675 43,376,020 Alfred D. Kingsley 78,869,742 5,527,521 43,376,020 Andrew J. Last 80,339,227 4,058,036 43,376,020 Louis E. Silverman 82,542,629 1,854,634 43,376,020
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Insight Molecular Diagnostics Inc. shareholders approved To ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accountants for the fiscal year ending December 31, 2023. at the 2023-06-23 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-23
Exact text from the filing
2. Ratification of Independent Registered Public Accounting Firm Shares Voted For Against Abstained Broker Non-Votes 126,399,465 714,459 659,359 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Insight Molecular Diagnostics Inc. shareholders approved To approve, on an advisory basis, the Company’s named executive officer compensation in fiscal 2022. at the 2023-06-23 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-23
Exact text from the filing
3. Advisory Vote to Approve Named Executive Officer Compensation Shares Voted For Against Abstained Broker Non-Votes 78,956,918 5,312,531 127,814 43,376,020
View on SEC.gov